Trials / Completed
CompletedNCT00819884
To Evaluate 24-hr Glucose After OD vs BD AZD1656
A Randomised, Two Way Cross-Over, Single-Blind, Phase I Study to Evaluate 24-hr Glucose Profiles in Patients With T2DM When Dosed OD and BD on Top of Metformin for Four Days With AZD1656
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the 24-hour glucose profiles in diabetic patients treated with metformin following once daily and twice daily oral dosing
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD1656 | Oral suspension |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2009-01-09
- Last updated
- 2009-05-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00819884. Inclusion in this directory is not an endorsement.